Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
46
Frequently Asked Questions
What is Market Cap of Carisma Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Carisma Therapeutics Inc market cap is $16.79M.
What is the 52-week high for Carisma Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Carisma Therapeutics Inc 52 week high is $1.27 as of September 08, 2025.
What is the 52-week low for Carisma Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Carisma Therapeutics Inc 52 week low is $0.1417 as of September 08, 2025.
What is Carisma Therapeutics Inc stock price today?
Carisma Therapeutics Inc stock price today is $0.4019.
What was Carisma Therapeutics Inc stock price yesterday?
Carisma Therapeutics Inc stock price yesterday was $0.32.
What is the PE ratio of Carisma Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Carisma Therapeutics Inc’s P/E ratio is -0.34.
What is the Price-to-Book ratio of Carisma Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Carisma Therapeutics Inc P/B ratio is -0.3651.
What is the 50-day moving average of Carisma Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Carisma Therapeutics Inc 50-day moving average is $0.3376.
How many employess does Carisma Therapeutics Inc has?